*Some Market data delayed by 15 mins.

Gossamer Bio, Inc. Common Stock

Symbol: GOSS (NASDAQ)
2.53 ▼ (-3.99%) -0.105

Company Description:
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Key Stats
  • Today's Open: $2.59
  • Today's High: $2.695
  • Today's Low: $2.465
  • Today's Volume: 3.51M
  • Yesterday Close: $2.63
  • Yesterday High: $2.84
  • Yesterday Low: $2.57
  • Yesterday Volume: 4.70M
  • Last Min Volume: 2.07K
  • Last Min High: $2.525
  • Last Min Low: $2.525
  • Last Min VWAP: $2.525
Company Profile
  • Name: Gossamer Bio, Inc. Common Stock
  • Website: https://www.gossamerbio.com
  • Listed Date: 2019-02-08
  • Location: SAN DIEGO, CA
  • Market Status: Active
  • CIK Number: 0001728117
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $601.96M
  • Round Lot: 100
  • Outstanding Shares: 228.88M
  • Asset Type: CS
RECENT FILINGS FOR GOSS
Filing Date Filing Type Format
2025-09-25 8-K View
2025-08-20 4 View
2025-08-05 8-K View
2025-08-05 10-Q View
2025-07-29 SCHEDULE 13G View
2025-07-17 SCHEDULE 13G View
2025-06-26 4 View
2025-06-26 4 View
2025-06-26 4 View
2025-06-26 4 View
2025-06-26 4 View
2025-06-26 4 View
2025-06-25 8-K View
2025-06-16 8-K View
2025-05-15 8-K View
2025-05-15 10-Q View
2025-04-29 ARS View
2025-04-29 DEFA14A View
2025-04-29 DEF 14A View
2025-03-13 S-8 View

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.